Cyamopsis Biotech (India) Private Limited

Cyamopsis Biotech (India) Private Limited - chemicals and materials in Sirsa, Haryana, India. FY 2026 financials & compliance.
CIN U01136HR2012PTC045395 Incorporated 14 March 2012 ROC Delhi HQ Sirsa, Haryana, India
Active Private Limited Company chemicals and materials MSME · Small
Revenue · FY 2025
₹37.18 Cr
▲ 4% YoY
Net profit · FY 2025
₹29.81 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹1.82 Cr
EBITDA margin 4.9%
Authorised capital
₹7.3 Cr
Registered with MCA
Paid-up capital
₹7.26 Cr
Issued & subscribed
Open charges
₹17.28 Cr
Satisfied ₹13.27 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
4
Provident fund records

About Cyamopsis Biotech (India) Private Limited

Data last updated:

Cyamopsis Biotech (India) Private Limited is a private limited company based in Sirsa, Haryana, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 14 March 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U01136HR2012PTC045395. Its GSTIN is 06AAECD1986H1ZK (Haryana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹7.3 Cr and a paid-up capital of ₹7.26 Cr. It was formerly known as Dada Ganpati Guar Products Private Limited. It is led by directors including Anju Jalan and Suresh Kumar Singla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12th Km Stone Hisar Road Village – Moriwala, Sirsa, Haryana, India – 125060.

As per the financials filed for FY 2025, the company reported a revenue of ₹37.18 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹29.81 Lakh (net margin 0.8%) and EBITDA of ₹1.82 Cr (EBITDA margin 4.9%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.

The company has about 4 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹17.28 Cr and satisfied charges of ₹13.27 Cr on record. The company has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹6.67 Cr; the latest was in June 2016. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 23 overdue payments to 1 micro and small supplier.

Cyamopsis Biotech (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-17-0004119). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cyamopsisbiotech.com.

Company details

CIN U01136HR2012PTC045395
Registration Number 045395
Incorporation Date 14 March 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-17-0004119

Recognitions & Rankings of Cyamopsis Biotech (India)

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-HR-17-0004119

Contact details

Cyamopsis Biotech (India) Private Limited's registered office is in Sirsa, Haryana. Its website is cyamopsisbiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    12th Km Stone Hisar Road Village – Moriwala, Sirsa, Haryana, India – 125060
  • Industry
    Chemicals and Materials, Specialty Chemicals

To see the full contact details of Cyamopsis Biotech (India) Private Limited, buy the company report.

Comprehensive company report
Cyamopsis Biotech (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Cyamopsis Biotech (India) is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Cyamopsis Biotech (India) Private Limited, buy the company report.

Financials of Cyamopsis Biotech (India) Private Limited

FY 2025 filings available

Cyamopsis Biotech (India) Private Limited reported revenue of ₹37.18 Cr (up 4% YoY) for FY 2025.

Revenue · FY 2025
₹37.18 Cr ▲ 4%
Net profit · FY 2025
₹29.81 Lakh margin 0.8%
EBITDA · FY 2025
₹1.82 Cr margin 4.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 1%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 12%
5 years · compounded
▲ 21%

Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.82 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹29.81 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.9%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cyamopsis Biotech (India) Private Limited, buy the company report.

Board of directors of Cyamopsis Biotech (India) Private Limited

Cyamopsis Biotech (India) has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anju JalanDirector14 Mar 201214 Years 8 MonthsCurrent
Suresh Kumar SinglaDirector14 Mar 201214 Years 8 MonthsCurrent
Raj Kumar JalanDirector14 Mar 201214 Years 8 MonthsCurrent
Pankaj KhemkaDirector14 Mar 201214 Years 8 MonthsCurrent

Auditor

Cyamopsis Biotech (India) Private Limited is audited by S. L. Goyal & Co. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
S. L. Goyal & Co.FY 2022001903N

Shareholding

The shareholding of Cyamopsis Biotech (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cyamopsis Biotech (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.28 Cr
Satisfied charges
₹13.27 Cr
Breakdown by lending institutions
Others₹15.30 Cr
Axis Bank Limited₹1.78 Cr
Hdfc Bank Limited₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jul 2024100961112Others₹15.3 CrOpen
16 May 2024100921536Axis Bank Limited₹1.68 CrOpen
05 Apr 2024100917906Axis Bank Limited₹10 LakhOpen
26 Sep 2023100794100Hdfc Bank Limited₹19.81 LakhOpen
29 Nov 201210395326State Bank of India₹13.27 CrSatisfied

To see the full charge records of Cyamopsis Biotech (India) Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Cyamopsis Biotech (India) Private Limited has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹6.67 Cr; the latest was in June 2016.

Total deals
3
Funding rounds
2
Rights issue
1
Disclosed funding
₹6.67 Cr

Deals on record (3 of 3)

WhenDealAmountParties
Jun 2016Rights issue₹2.4 CrInvestors: Ohm Entertainment Private Limited , 3 individuals
Nov 2012Funding round₹2.91 CrInvestors: Blooms Texent Private Limited , 3 individuals
Jul 2012Funding round₹3.75 CrInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Cyamopsis Biotech (India) Private Limited was last rated by Brickwork on 24 May 2021.

Rating agencyRated onRating
Brickwork24 May 2021

To see the full credit ratings and regulatory alerts of Cyamopsis Biotech (India) Private Limited, buy the company report.

MSME payment delays

Cyamopsis Biotech (India) Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 23 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
M/S Dada Ganpati Engineers

To see the full MSME payment records of Cyamopsis Biotech (India) Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Cyamopsis Biotech (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
06AAECD1986H1ZKHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Cyamopsis Biotech (India) Private Limited, buy the company report.

Recent activity

Cyamopsis Biotech (India) Private Limited has 4 board changes on record since 2012: 4 appointments. The latest: Anju Jalan was appointed as Director on 14 Mar 2012.

Charges
A charge with Others of Rs. 15.30 Cr registered on 27 Jul 2024 with Charge ID 100961112 was modified on 26 Dec 2025.
Charges
A charge registered on 29 Nov 2012 via Charge ID 10395326 with State Bank Of India was fully satisfied on 26 Nov 2025.
AGM
Cyamopsis Biotech (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cyamopsis Biotech (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 15.30 Cr with Charge ID 100961112 was registered on 27 Jul 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.68 Cr with Charge ID 100921536 was registered on 16 May 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100917906 was registered on 05 Apr 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100794100 was registered on 26 Sep 2023.
Charges
A charge with State Bank Of India of Rs. 13.27 Cr registered on 29 Nov 2012 with Charge ID 10395326 was modified on 10 Mar 2023.
Charges
A charge with State Bank Of India amounted to Rs. 13.27 Cr with Charge ID 10395326 was registered on 29 Nov 2012.
Appointed
Anju Jalan was appointed as Director.
Appointed
Pankaj Khemka was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Cyamopsis Biotech (India) is an active private limited company based in Sirsa, Haryana, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 14 March 2012 (14+ years old) and is registered under CIN U01136HR2012PTC045395.

Cyamopsis Biotech (India) has 4 current directors:

The latest financial statements of Cyamopsis Biotech (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Cyamopsis Biotech (India) is 06AAECD1986H1ZK, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Cyamopsis Biotech (India) is U01136HR2012PTC045395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cyamopsis Biotech (India) was incorporated on 14 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.

Cyamopsis Biotech (India) has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹6.67 Cr; the latest was in June 2016.

Anju Jalan was appointed as Director on 14 Mar 2012. Pankaj Khemka was appointed as Director on 14 Mar 2012. Raj Kumar Jalan was appointed as Director on 14 Mar 2012. Cyamopsis Biotech (India) has 4 board changes on record in total.

Yes, Cyamopsis Biotech (India) is registered as a small enterprise under Udyam registration (number: UDYAM-HR-17-0004119).

Cyamopsis Biotech (India) has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 23 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.

Cyamopsis Biotech (India) can be reached through the website cyamopsisbiotech.com. Its registered office is in Sirsa, Haryana, India.